Form D · Biotechnology

Driver Bioengineering, Inc.

San Francisco, CA · CIK 0001778974

Offering snapshot reported Feb 9, 2022 · SEC filing

Reported sold
$23.2M
Offering amount: $23.6M
Investors reported
65
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 28, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11.6M$23.2MJun 11, 2019: $16,302,067.00Jun 11, 2019Feb 9, 2022: $23,200,284.00Feb 9, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$16,302,067 → $23,200,284
  • Reported investors39 → 65

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 9, 2022Amendment$23,200,284$6,898,217vs Jun 11, 201965SEC filing
Jun 11, 2019Initial$16,302,067No comparison39SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-341581

Source: Form D, filed Feb 9, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scott Dylla Director
Wladimir Hogenhuis Executive
Benjamin Wang Director
Gusti Zeiner Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
329 Oyster Point Blvd 3rd Floor
San Francisco, CA, 94080